NCT00463450View on ClinicalTrials.gov

Efficacy of Gynodian® Depot in Women With Impaired Well-being

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

April 30, 2004

Conditions
Hormone Replacement Therapy
Interventions
DRUG

Gynodian® Depot (BAY86-5032)

Injection monthly

DRUG

BAY86-4980

orally

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

Navitas Life Sciences GmbH

INDUSTRY

collaborator

LKF Laboratory

UNKNOWN

lead

Bayer

INDUSTRY

NCT00463450 - Efficacy of Gynodian® Depot in Women With Impaired Well-being | Biotech Hunter | Biotech Hunter